Area of research
Oncology · Molecular Biology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Pancreatic and Hepatic Oncology Research, Cancer Treatment and Pharmacology, and Axon Guidance and Neuronal Signaling.
Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids
The basis for future personalized therapy approaches – Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pancreatic cancer patients
Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study
Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer
Cachexia-Affected Survival Based on Inflammatory Parameters Compared to Complex Conventional Nutritional Assessments in Patients with Pancreatic Cancer and Other Gastrointestinal Tumors—The CONKO 020 Investigation
Cytokine‐armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary <scp>CD56<sup>dim</sup>CD16<sup>dim</sup></scp> natural killer cells
Recurrent Intracranial Ewing Sarcoma
Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer
Leveraging Large Language Models for Decision Support in Personalized Oncology
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade